European Hematology Exam
The 4th European Hematology Exam has been postponed to Thursday October 8, 2020 from 11:00-13:30 CEST, in Switzerland (Bern), Turkey (Istanbul), Spain (Madrid), Greece (Athens), Iraq (Baghdad), Armenia (Yerevan), Bulgaria (Sofia), Estonia (Tallinn), Portugal (Lisbon), Saudi Arabia (Riyadh), Lithuania and Luxembourg.
Due to COVID-19 travel restrictions, there will not be a central exam location. Instead, local parallel sessions will take place in 12 countries, organized by the applicable national hematology societies. These sessions are only open to national candidates.
All locations will take into account local COVID-19 regulations.
Is there no session in your country? You could try to contact your national society and inform them of the possibility to organize the exam. If your national society would like more information, ask them to contact EHA before August 17 at email@example.com.
Did you already register for the European Exam? You have received an email in which we offer you to transfer your registration to a local session on October 8 (if applicable), to transfer your registration to the 2021 Exam, or to cancel. You can confirm your decision by completing this form.
What is the European Hematology Exam?
The European Hematology Exam aims to certify excellent knowledge according to the criteria and topics of the European Hematology Curriculum. While the right to practice will still be granted by national authorities, the European Hematology Exam will be regarded as an extra quality stamp for hematologists. It is an important step in the harmonization of hematology training/education in Europe, and will support professional mobility.
The exam consists of 100 multiple choice questions (MCQ) in English, covering all 8 sections of the European Hematology Curriculum, and will take 2.5 hours. Here you will find some sample questions.
Who should take part in the exam?
The exam is mainly aimed at hematologists who just finalized their specialty training, and is also open to mid-career and senior hematologists who would like to examine if their knowledge is still up-to-date.